“We are entering 2024 with a solid foundation. We believe our commitment to execution, maximizing the performance of our new products, and delivering the next wave of pipeline innovation will fuel Pfizer’s growth and make a difference in the lives of patients everywhere.” D...
New Molecular EntityProduct Enhancement Compound Type i BiologicSmall MoleculeVaccine Project Status i CurrentDiscontinuedProject Advanced Adjust filters or reset allto view products Phase 1 PADCEV (enfortumab vedotin) BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (Biologic)OncologyProduct EnhancementBi...
Our ambitions are big and our product pipeline has never been stronger. We’re energized and inspired to apply science and our global resources to develop and deliver breakthrough therapies to people everywhere.To Our Investors Why Invest Financial Reports Events and Presentations Stock Information...
Pipeline Developments A comprehensive update of Pfizer’s development pipeline was published today and is now available at www.pfizer.com/science/drug-product-pipeline. It includes an overview of Pfizer’s research and a list of compounds in development with targeted indication and phase of developmen...
Pfizer Inc., New York, shared its approach to pharmacogenomics and how it is applied to their drug discovery pipeline, this week at PharmaDiscovery2004, held in New Yorks Jacob Javits Convention Center. For one, the company defines pharmacogenetics and pharmaco...
So in my role as chair with the PMT since I joined Pfizer, partnering with Chris, we have been working through that pipeline, starting with the late-stage assets, but then moving earlier, to make sure the decisions we make drug by drug, indication by indication are ones that are gonna ...
“Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates. The most advanced of them, danuglipron, has demonstrated good efficacy in a twice-daily formulation, and we believe a once-dail...
Access to state-of-the-art drug development and formulation technology. These opportunities will provide participants with diverse career options at the end of the program. Learn More Program Opportunities Concept Evaluation and Research Drug Product Development Core Rotation Pipeline Development Core ...
network to identify high-potential assets. More broadly, he will also provide strategic guidance on the company's AI initiatives, advising on the development of its AI platform for asset search, evaluation, and deep research ...
New Molecular EntityProduct Enhancement Compound Type i BiologicSmall MoleculeVaccine Project Status i CurrentDiscontinuedProject Advanced Adjust filters or reset allto view products Phase 1 PADCEV (enfortumab vedotin) BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer (Biologic)OncologyProduct EnhancementBi...